Genetically engineered yeast makes medicinal plant products

Nature
2020.0

Abstract

An engineered strain of yeast produces tropane alkaloids.Yeast has been engineered to convert simple sugars and amino acids into drugs that inhibit a neurotransmitter molecule. The work marks a step towards making the production of these drugs more reliable and sustainable.

DOI： 10.1038/d41586-020-02461-8

Knowledge Graph

Similar Paper

Genetically engineered yeast makes medicinal plant products
Nature 2020.0
Biosynthesis of medicinal tropane alkaloids in yeast
Nature 2020.0
Engineered yeast brews precursors of anticancer drug vinblastine
Nature 2022.0
Complete biosynthesis of noscapine and halogenated alkaloids in yeast
Proceedings of the National Academy of Sciences 2018.0
Engineering cellular metabolite transport for biosynthesis of computationally predicted tropane alkaloid derivatives in yeast
Proceedings of the National Academy of Sciences 2021.0
Microbial Cell Factories for Tetrahydroisoquinoline Alkaloid Production
ChemBioChem 2021.0
A microbial biomanufacturing platform for natural and semisynthetic opioids
Nature Chemical Biology 2014.0
Producing aglycons of ginsenosides in bakers' yeast
Scientific Reports 2014.0
Engineered biosynthesis of plant heteroyohimbine and corynantheine alkaloids in Saccharomyces cerevisiae
Journal of Industrial Microbiology and Biotechnology 2024.0
Efficient production of vindoline from tabersonine by metabolically engineered Saccharomyces cerevisiae
Communications Biology 2021.0